Worldwide Tissue Banking Industry to 2025 – Technological Advances in Drug Discovery and Development are Driving Growth – ResearchAndMarkets.com | Financial Buzz

Worldwide Tissue Banking Industry to 2025 – Technological Advances in Drug Discovery and Development are Driving Growth – ResearchAndMarkets.com

The “Tissue Banking Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering.

Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide.

According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately 60% of all deaths worldwide. The global burden of chronic diseases is expected to reach 57%, by 2020. This trend is expected to affect the emerging countries the most, as population growth is anticipated to be most significant in developing areas. Consequently, rising burden of chronic diseases is expected to drive the overall growth of the tissue banking market. However, stringent regulatory scenario is expected to restrain the growth of the global market in the forecast period.

Companies Mentioned

  • AMS Biotechnology (Europe) Limited
  • Avantor, Inc (VWR International)
  • Sartorius AG
  • Brooks Lifesciences (Brooks Automation Inc.)
  • Bio-Rad Laboratories Inc.
  • Eppendorf AG
  • Hamilton Company
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.

Key Market Trends

Equipment Segment is Expected to Show Better Growth in the Forecast Period

Based on the product, it is segmented into equipment and media and consumables. The equipment segment is expected to grow at a faster pace during the forecast period. The key factor contributing to the growth of the segment is mainly driven by growing research activities and increasing the focus of market players on product development, along with the rising burden of chronic diseases. According to the World Health Organization (WHO), the four major chronic diseases which include cardiovascular diseases followed by cancer, respiratory diseases and diabetes account for most deaths. Factors, such as the aging population, lifestyles changes, leads to long-term health problems, and their treatment can be expensive. Additionally, Increasing government initiatives and rising demand for transplantation is expected to boost the studied market.

North America is Estimated to Account for the Largest Share in the Tissue Banking Market

North America holds a major share in the global tissue banking market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The United States market is driven by increasing R&D activities, along with rising burden of chronic diseases. According to Center for Disease Control and Prevention (CDC), 6 in 10 adults in the United States have a chronic disease. Different pharmaceutical/ biotech companies, academia, and research institutes are utilizing tissue banks for the storage of various samples. Hence, North America region is expected to grow at a faster rate due to rising preclinical activities by pharmaceutical companies, and growing research in this region.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Healthcare Expenditure

4.2.2 Growing Burden of Chronic Diseases

4.2.3 Technological Advances in Drug Discovery and Development

4.3 Market Restraints

4.3.1 Stringent Regulatory Scenario

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product

5.1.1 Equipment

5.1.1.1 Cryopreservation Equipment

5.1.1.2 Thawing Equipment

5.1.1.3 Quality Control Equipment

5.1.1.4 Others

5.1.2 Media and Consumables

5.2 By Application

5.2.1 Therapeutics

5.2.2 Medical Research

5.2.3 Other Applications

5.3 Geography

5.3.1 North America

5.3.1.1 United States

5.3.1.2 Canada

5.3.1.3 Mexico

5.3.2 Europe

5.3.2.1 Germany

5.3.2.2 United Kingdom

5.3.2.3 France

5.3.2.4 Italy

5.3.2.5 Spain

5.3.2.6 Rest of Europe

5.3.3 Asia-Pacific

5.3.3.1 China

5.3.3.2 Japan

5.3.3.3 India

5.3.3.4 Australia

5.3.3.5 South Korea

5.3.3.6 Rest of Asia-Pacific

5.3.4 Middle-East & Africa

5.3.4.1 GCC

5.3.4.2 South Africa

5.3.4.3 Rest of Middle-East and Africa

5.3.5 South America

5.3.5.1 Brazil

5.3.5.2 Argentina

5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 AMS Biotechnology (Europe) Limited

6.1.2 Avantor, Inc (VWR International)

6.1.3 Sartorius AG

6.1.4 Brooks Lifesciences (Brooks Automation Inc.)

6.1.5 Bio-Rad Laboratories Inc.

6.1.6 Eppendorf AG

6.1.7 Hamilton Company

6.1.8 Merck KGaA

6.1.9 Thermo Fisher Scientific, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/4w16v4

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!